SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023)

The Spanish Society of Medical Oncology (SEOM) last published clinical guidelines on venous thromboembolism (VTE) and cancer in 2019, with a partial update in 2020. In this new update to the guidelines, SEOM seeks to incorporate recent evidence, based on a critical review of the literature, to provi...

Full description

Saved in:
Bibliographic Details
Published in:Clinical & translational oncology 2024-11, Vol.26 (11), p.2877-2901
Main Authors: Morán, Laura Ortega, Mateo, Francisco José Pelegrín, Balanyà, Rut Porta, Revuelta, Jacobo Rogado, Martínez, Silverio Ros, Fombella, José Pablo Berros, Vázquez, Elena María Brozos, Caro, Natalia Luque, Langa, José Muñoz, Fernández, Mercedes Salgado
Format: Article
Language:English
Subjects:
Anticoagulants - therapeutic use
Clinical Guides in Oncology
Heparin, Low-Molecular-Weight - therapeutic use
Humans
Medical Oncology - standards
Medicine
Medicine & Public Health
Neoplasms - complications
Neoplasms - drug therapy
Oncology
Societies, Medical
Venous Thromboembolism - drug therapy
Venous Thromboembolism - etiology
Venous Thromboembolism - prevention & control
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Spanish Society of Medical Oncology (SEOM) last published clinical guidelines on venous thromboembolism (VTE) and cancer in 2019, with a partial update in 2020. In this new update to the guidelines, SEOM seeks to incorporate recent evidence, based on a critical review of the literature, to provide practical current recommendations for the prophylactic and therapeutic management of VTE in patients with cancer. Special clinical situations whose management and/or choice of currently recommended therapeutic options (low-molecular-weight heparins [LMWHs] or direct-acting oral anticoagulants [DOACs]) is controversial are included.
ISSN:1699-3055
1699-048X
1699-3055
DOI:10.1007/s12094-024-03605-2